Astera Labs (NASDAQ:ALAB) Shares Up 13.3% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price shot up 13.3% during trading on Tuesday . The stock traded as high as $255.96 and last traded at $244.26. 9,386,312 shares changed hands during trading, an increase of 72% from the average session volume of 5,445,108 shares. The stock had previously closed at $215.58.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on ALAB shares. UBS Group began coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target for the company. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Needham & Company LLC increased their price objective on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Susquehanna raised their target price on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. lifted their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Fifteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Trading Up 13.3%

The stock’s 50-day moving average price is $157.31 and its 200-day moving average price is $156.64. The stock has a market cap of $41.87 billion, a price-to-earnings ratio of 165.04, a P/E/G ratio of 3.08 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insiders Place Their Bets

In other news, General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $117.47, for a total value of $1,174,700.00. Following the transaction, the general counsel directly owned 128,084 shares of the company’s stock, valued at $15,046,027.48. The trade was a 7.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director directly owned 319,863 shares of the company’s stock, valued at $34,420,457.43. This represents a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,290,546 shares of company stock valued at $211,225,088. Insiders own 12.50% of the company’s stock.

Institutional Trading of Astera Labs

Hedge funds have recently bought and sold shares of the business. Assetmark Inc. increased its stake in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. Reflection Asset Management purchased a new position in shares of Astera Labs in the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC grew its holdings in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares in the last quarter. Hilltop National Bank increased its position in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC purchased a new stake in shares of Astera Labs during the fourth quarter valued at approximately $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.